Osteopontin – A potential biomarker of advanced liver disease
Cirrhosis is a primary cause of liver-related mortality and morbidity. The basic process driving chronic liver disease to cirrhosis is accelerated fibrogenesis. Although the pathogenesis of liver cirrhosis is a multifactorial process, the essential step in the evolution of liver fibrosis is the acti...
Main Authors: | Radan Bruha, Libor Vitek, Vaclav Smid |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | Annals of Hepatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268120300016 |
Similar Items
-
Usefulness of serum osteopontin level as a noninvasive parameter of portal hypertension
by: Ayman M Fouad, et al.
Published: (2019-01-01) -
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
by: Wah-Kheong Chan, et al.
Published: (2023-09-01) -
The prevalence of nonalcoholic liver steatosis in patients with type 2 diabetes mellitus in the Czech Republic
by: Karel Dvorak, et al.
Published: (2015-09-01) -
Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients
by: Yu Jun Wong, et al.
Published: (2023-01-01) -
Investigation of computed tomography findings of portal hypertension at non-alcoholic fatty liver disease
by: Fatma Kulali, et al.
Published: (2016-09-01)